Skip to main content

Table 1 Demographics and clinical presentation in all patients of the study

From: Large inferior retinectomies for proliferative vitreoretinopathy in silicone oil-filled eyes

Patient number

Initial BCVA (LogMAR)

Final BCVA (LogMAR)

Sex

Age (years)

Follow-up period

PVR grade

Final macular status

Extent of retinectomy (degrees)

Late complications

#1

2.4

2.1

Female

30

4 months

C1

Attached

150o

None

#2

2.1

1.3

Male

58

4 months

C2

Attached

180o

None

#3

2.4

1.3

Female

68

5 months

C2

Attached

120o

None

#4

2.1

2.1

Male

71

46 months

C3

Attached + SB + SO removal

120o

None

#5

2.7

2.4

Female

44

45 months

C2

Attached + SB

160o

Shallow AC + Optic disk atrophy

#6

2.4

1.3

Male

52

36 months

C1

Detached + SB

270o

Re-detachment

#7

2.4

2.4

Male

63

49 months

C2

Detached + SB

120o

Re-detachment + Hypotony

#8

2.4

1.3

Male

48

43 months

C3

Attached + SB

180o

optic disk atrophy

#9

2.1

1.3

Male

46

44 months

C2

Attached + SB

160o

ERM

#10

2.4

2.1

Male

62

27 months

C1

Attached

160o

None

#11

2.1

0.7

Male

57

72 months

C3

Attached + SO removal

180o

ERM

#12

2.7

1.3

Male

56

84 months

C1

Attached

180o

None

#13

1.3

0.7

Female

68

72 months

C1

Attached

180o

Cystoid macular edema

#14

2.1

0.7

Male

52

96 months

C3

Attached

180o

Cystoid macular edema

#15

1.3

0.7

Male

55

60 months

C1

Attached + SO removal

180o

None

#16

2.1

1.3

Female

44

95 months

C1

Attached + SO removal

270o

None

#17

2.1

1.3

Male

56

4 months

C2

Attached + SB

180o

None

#18

2.1

1.3

Female

65

6 months

C1

Attached

180o

None

  1. BCVA best-corrected visual acuity, SB scleral buckling, SO silicone oil, AC anterior chamber, ERM epiretinal membrane, PVR proliferative vitreoretinopathy